Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Options
Early notable gainers among liquid option names on April 21st » 09:55
04/21/21
04/21
09:55
04/21/21
09:55
ISRG

Intuitive Surgical

$847.01 /

+35.02 (+4.31%)

, NCLH

Norwegian Cruise Line

$27.84 /

+1.09 (+4.07%)

, CTXS

Citrix

$141.96 /

+3.84 (+2.78%)

, DISH

Dish

$37.58 /

+0.69 (+1.87%)

, EW

Edwards Lifesciences

$92.83 /

+3.21 (+3.58%)

Notable gainers among…

Notable gainers among liquid option names this morning include Intuitive Surgical (ISRG) $863.24 +50.95, Norwegian Cruise Line (NCLH) $28.38 +1.63, Citrix (CTXS) $143.56 +5.35, Dish Network (DISH) $38.21 +1.33, and Edwards Lifesciences (EW) $92.79 +3.16.

ShowHide Related Items >><<
NCLH Norwegian Cruise Line
$27.84 /

+1.09 (+4.07%)

ISRG Intuitive Surgical
$847.01 /

+35.02 (+4.31%)

EW Edwards Lifesciences
$92.83 /

+3.21 (+3.58%)

DISH Dish
$37.58 /

+0.69 (+1.87%)

CTXS Citrix
$141.96 /

+3.84 (+2.78%)

ISRG Intuitive Surgical
$847.01 /

+35.02 (+4.31%)

04/21/21 SVB Leerink
Intuitive Surgical price target raised to $860 from $825 at SVB Leerink
04/21/21 Wells Fargo
Intuitive Surgical price target raised to $892 from $879 at Wells Fargo
04/21/21 Deutsche Bank
Intuitive Surgical price target raised to $825 from $690 at Deutsche Bank
04/21/21 JPMorgan
Intuitive Surgical price target raised to $900 from $840 at JPMorgan
NCLH Norwegian Cruise Line
$27.84 /

+1.09 (+4.07%)

04/20/21 Goldman Sachs
Norwegian Cruise Line upgraded to Buy from Neutral at Goldman Sachs
03/24/21 Stifel
Cruiseline stock selloff 'unwarranted,' says Stifel
03/18/21 UBS
Norwegian Cruise Line price target raised to $32 from $21 at UBS
03/16/21 JPMorgan
Norwegian Cruise Line price target raised to $36 from $33 at JPMorgan
CTXS Citrix
$141.96 /

+3.84 (+2.78%)

04/21/21
Fly Intel: Top five analyst upgrades
04/21/21 Jefferies
Citrix upgraded to Buy from Hold at Jefferies
04/13/21 BofA
Citrix reinstated with an Underperform at BofA
03/03/21 Citi
Citrix assumed with a Buy at Citi
DISH Dish
$37.58 /

+0.69 (+1.87%)

03/08/21 Citi
Dish could pursue deal for TDS or U.S. Cellular for rural coverage, says Citi
02/25/21 Oppenheimer
Verizon, AT&T downgraded to Perform on valuation at Oppenheimer
02/23/21
Fly Intel: Top five analyst downgrades
02/23/21 Pivotal Research
Dish downgraded to Hold from Buy at Pivotal Research
EW Edwards Lifesciences
$92.83 /

+3.21 (+3.58%)

04/21/21 Raymond James
Edwards Lifesciences price target raised to $101 from $96 at Raymond James
04/21/21 Wells Fargo
Edwards Lifesciences price target raised to $93 from $87 at Wells Fargo
04/21/21 Canaccord
Edwards Lifesciences price target raised to $103 from $94 at Canaccord
04/21/21 Piper Sandler
Edwards Lifesciences price target raised to $105 from $97 at Piper Sandler
NCLH Norwegian Cruise Line
$27.84 /

+1.09 (+4.07%)

ISRG Intuitive Surgical
$847.01 /

+35.02 (+4.31%)

EW Edwards Lifesciences
$92.83 /

+3.21 (+3.58%)

DISH Dish
$37.58 /

+0.69 (+1.87%)

CTXS Citrix
$141.96 /

+3.84 (+2.78%)

  • 05
    Mar
  • 18
    Nov
  • 17
    Jul
  • 06
    May
NCLH Norwegian Cruise Line
$27.84 /

+1.09 (+4.07%)

DISH Dish
$37.58 /

+0.69 (+1.87%)

NCLH Norwegian Cruise Line
$27.84 /

+1.09 (+4.07%)

ISRG Intuitive Surgical
$847.01 /

+35.02 (+4.31%)

EW Edwards Lifesciences
$92.83 /

+3.21 (+3.58%)

DISH Dish
$37.58 /

+0.69 (+1.87%)

NCLH Norwegian Cruise Line
$27.84 /

+1.09 (+4.07%)

ISRG Intuitive Surgical
$847.01 /

+35.02 (+4.31%)

EW Edwards Lifesciences
$92.83 /

+3.21 (+3.58%)

DISH Dish
$37.58 /

+0.69 (+1.87%)

Recommendations
Edwards Lifesciences price target raised to $101 from $96 at Raymond James » 08:08
04/21/21
04/21
08:08
04/21/21
08:08
EW

Edwards Lifesciences

/

+

Raymond James analyst…

Raymond James analyst Jayson Bedford raised the firm's price target on Edwards Lifesciences to $101 from $96 and keeps an Outperform rating on the shares. Bedford tells investors in a research note that the Q1 results should inspire more confidence in the numbers for the rest of the year, and expects sentiment to improve, especially as the group benefits from the broader re-opening of the economy, which should lead to a steady improvement in volumes.

ShowHide Related Items >><<
EW Edwards Lifesciences
/

+

EW Edwards Lifesciences
/

+

04/21/21 Wells Fargo
Edwards Lifesciences price target raised to $93 from $87 at Wells Fargo
04/21/21 Canaccord
Edwards Lifesciences price target raised to $103 from $94 at Canaccord
04/21/21 Piper Sandler
Edwards Lifesciences price target raised to $105 from $97 at Piper Sandler
04/15/21 Atlantic Equities
Atlantic Equities starts Edwards Lifesciences at Neutral
EW Edwards Lifesciences
/

+

EW Edwards Lifesciences
/

+

EW Edwards Lifesciences
/

+

Recommendations
Edwards Lifesciences price target raised to $93 from $87 at Wells Fargo » 08:03
04/21/21
04/21
08:03
04/21/21
08:03
EW

Edwards Lifesciences

$89.62 /

+1.16 (+1.31%)

Wells Fargo analyst Larry…

Wells Fargo analyst Larry Biegelsen raised the firm's price target on Edwards Lifesciences to $93 from $87 following quarterly results. The analyst keeps an Equal Weight rating on the shares.

ShowHide Related Items >><<
EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

04/21/21 Canaccord
Edwards Lifesciences price target raised to $103 from $94 at Canaccord
04/21/21 Piper Sandler
Edwards Lifesciences price target raised to $105 from $97 at Piper Sandler
04/15/21 Atlantic Equities
Atlantic Equities starts Edwards Lifesciences at Neutral
04/05/21 Evercore ISI
Evercore upgrades Edwards to Outperform ahead of its 'best pipeline cycle'
EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

Recommendations
Edwards Lifesciences price target raised to $103 from $94 at Canaccord » 07:24
04/21/21
04/21
07:24
04/21/21
07:24
EW

Edwards Lifesciences

$89.62 /

+1.16 (+1.31%)

Canaccord analyst William…

Canaccord analyst William Plovanic raised the firm's price target on Edwards Lifesciences to $103 from $94 and keeps a Buy rating on the shares. The analyst sees the company gaining momentum as the COVID headwinds abate and noted the company raised its adjusted guidance. He said the company continues to dominate the TAVR market and has a large future opportunity in TMTT.

ShowHide Related Items >><<
EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

04/21/21 Piper Sandler
Edwards Lifesciences price target raised to $105 from $97 at Piper Sandler
04/15/21 Atlantic Equities
Atlantic Equities starts Edwards Lifesciences at Neutral
04/05/21 Evercore ISI
Evercore upgrades Edwards to Outperform ahead of its 'best pipeline cycle'
04/05/21 Evercore ISI
Edwards Lifesciences upgraded to Outperform from In Line at Evercore ISI
EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

Recommendations
Edwards Lifesciences price target raised to $105 from $97 at Piper Sandler » 04:59
04/21/21
04/21
04:59
04/21/21
04:59
EW

Edwards Lifesciences

$89.62 /

+1.16 (+1.31%)

Piper Sandler analyst…

Piper Sandler analyst Adam Maeder raised the firm's price target on Edwards Lifesciences to $105 from $97 and reiterates an Overweight rating on the shares following the Q1 beat. It was "encouraging to hear" that Edwards exited Q1 with improving momentum, which sets the stage for continued procedure recovery and a strong back-half of the year, Maeder tells investors in a research note.

ShowHide Related Items >><<
EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

04/15/21 Atlantic Equities
Atlantic Equities starts Edwards Lifesciences at Neutral
04/05/21 Evercore ISI
Evercore upgrades Edwards to Outperform ahead of its 'best pipeline cycle'
04/05/21 Evercore ISI
Edwards Lifesciences upgraded to Outperform from In Line at Evercore ISI
01/13/21 Piper Sandler
MCIT finalized rule 'important win' for medical technology, says Piper Sandler
EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

On The Fly
Fly Intel: After-Hours Movers » 19:07
04/20/21
04/20
19:07
04/20/21
19:07
LRN

Stride

$30.75 /

+0.135 (+0.44%)

, HWC

Hancock Whitney

$40.83 /

-2.41 (-5.57%)

, EW

Edwards Lifesciences

$89.62 /

+1.16 (+1.31%)

, ORRF

Orrstown Financial

$21.45 /

-0.96 (-4.28%)

, ISRG

Intuitive Surgical

$809.85 /

-0.91 (-0.11%)

, THC

Tenet

$51.92 /

-0.62 (-1.18%)

, IBKR

Interactive Brokers

$74.23 /

-3.1 (-4.01%)

, KIN

Kindred Biosciences

$4.71 /

-0.02 (-0.42%)

, NOTV

Inotiv

$20.23 /

-1.22 (-5.69%)

, NFLX

Netflix

$549.33 /

-5.17 (-0.93%)

, CSX

CSX

$98.51 /

-0.18 (-0.18%)

, CPSH

CPS Technologies

$7.59 /

-0.45 (-5.60%)

, TRVG

Trivago

$3.32 /

-0.255 (-7.13%)

Check out this evening's…

ShowHide Related Items >><<
TRVG Trivago
$3.32 /

-0.255 (-7.13%)

THC Tenet
$51.92 /

-0.62 (-1.18%)

ORRF Orrstown Financial
$21.45 /

-0.96 (-4.28%)

NOTV Inotiv
$20.23 /

-1.22 (-5.69%)

NFLX Netflix
$549.33 /

-5.17 (-0.93%)

LRN Stride
$30.75 /

+0.135 (+0.44%)

KIN Kindred Biosciences
$4.71 /

-0.02 (-0.42%)

ISRG Intuitive Surgical
$809.85 /

-0.91 (-0.11%)

IBKR Interactive Brokers
$74.23 /

-3.1 (-4.01%)

EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

CSX CSX
$98.51 /

-0.18 (-0.18%)

CPSH CPS Technologies
$7.59 /

-0.45 (-5.60%)

LRN Stride
$30.75 /

+0.135 (+0.44%)

02/02/21 Morgan Stanley
Stride initiated with an Equal Weight at Morgan Stanley
10/28/20 BMO Capital
K12 price target lowered to $43 from $60 at BMO Capital
09/11/20 William Blair
K12 selloff on Miami-Dade contract loss overblown, says William Blair
09/10/20 BMO Capital
K12 stock overreacting after Miami-Dade cuts ties, says BMO Capital
HWC Hancock Whitney
$40.83 /

-2.41 (-5.57%)

04/07/21 Raymond James
Hancock Whitney upgraded to Strong Buy from Outperform at Raymond James
04/07/21 Raymond James
Hancock Whitney upgraded to Strong Buy from Outperform at Raymond James
01/21/21 Raymond James
Hancock Whitney price target raised to $46 from $28 at Raymond James
01/07/21 Jefferies
Hancock Whitney upgraded to Buy with $42 price target at Jefferies
EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

04/15/21 Atlantic Equities
Atlantic Equities starts Edwards Lifesciences at Neutral
04/05/21 Evercore ISI
Evercore upgrades Edwards to Outperform ahead of its 'best pipeline cycle'
04/05/21 Evercore ISI
Edwards Lifesciences upgraded to Outperform from In Line at Evercore ISI
01/13/21 Piper Sandler
MCIT finalized rule 'important win' for medical technology, says Piper Sandler
ORRF Orrstown Financial
$21.45 /

-0.96 (-4.28%)

09/24/20 Boenning & Scattergood
Orrstown Financial resumed with an Outperform at Boenning & Scattergood
ISRG Intuitive Surgical
$809.85 /

-0.91 (-0.11%)

04/01/21
Fly Intel: Top five analyst initiations
04/01/21 Citi
Intuitive Surgical initiated with a Buy at Citi
03/31/21 Piper Sandler
Intuitive Surgical price target raised to $735 from $730 at Piper Sandler
THC Tenet
$51.92 /

-0.62 (-1.18%)

04/09/21 Mizuho
Tenet price target raised to $55 from $48 at Mizuho
02/11/21 Credit Suisse
Tenet price target raised to $58 from $52 at Credit Suisse
02/11/21 Citi
Tenet price target raised to $58 from $50 at Citi
01/21/21 UBS
Tenet price target raised to $60 from $37 at UBS
IBKR Interactive Brokers
$74.23 /

-3.1 (-4.01%)

04/09/21 Jefferies
Charles Schwab price target raised to $76 from $70 at Jefferies
04/05/21 Goldman Sachs
Interactive Brokers price target raised to $83 from $73 at Goldman Sachs
03/05/21 Jefferies
Interactive Brokers initiated with a Buy at Jefferies
01/20/21 Compass Point
Interactive Brokers price target raised to $75 from $65 at Compass Point
KIN Kindred Biosciences
$4.71 /

-0.02 (-0.42%)

12/24/20 Barclays
Kindred atopic dermatitis portfolio could net $130M in sales, says Barclays
12/18/20 Alliance Global Partners
Kindred Biosciences price target lowered to $9.25 from $10.25 at Alliance Global Partners
12/14/20 Lake Street
Kindred Biosciences struck 'terrific arrangement' with Elanco, says Lake Street
12/01/20 Alliance Global Partners
Kindred price target lowered to $10.25 from $12.50 at Alliance Global
NOTV Inotiv
$20.23 /

-1.22 (-5.69%)

NFLX Netflix
$549.33 /

-5.17 (-0.93%)

04/20/21 Wells Fargo
Disney price target raised to $219 from $201 at Wells Fargo
04/19/21 Credit Suisse
Credit Suisse expects Netflix to report in line Q1/Q2 results
04/16/21 Loop Capital
Netflix shares already reflect tough comps, says Loop Capital
04/16/21 UBS
Netflix shares may be volatile in near-term, says UBS
CSX CSX
$98.51 /

-0.18 (-0.18%)

03/26/21 Vertical Research
CSX reinstated with a Hold at Vertical Research
03/25/21 Citi
Norfolk Southern shares have another $100 of potential upside, says Citi
01/25/21 Argus
CSX price target raised to $98 from $90 at Argus
01/22/21
Fly Intel: Top five analyst downgrades
CPSH CPS Technologies
$7.59 /

-0.45 (-5.60%)

TRVG Trivago
$3.32 /

-0.255 (-7.13%)

02/19/21 Citi
Trivago price target raised to $3.65 from $2.20 at Citi
02/11/21 Mizuho
Trivago price target raised to $2.70 from $2.30 at Mizuho
01/08/21 Mizuho
Trivago price target raised to $2.30 from $1.85 at Mizuho
12/08/20 Citi
Trivago price target raised to $2.20 from $1.50 at Citi
THC Tenet
$51.92 /

-0.62 (-1.18%)

ORRF Orrstown Financial
$21.45 /

-0.96 (-4.28%)

NOTV Inotiv
$20.23 /

-1.22 (-5.69%)

NFLX Netflix
$549.33 /

-5.17 (-0.93%)

LRN Stride
$30.75 /

+0.135 (+0.44%)

KIN Kindred Biosciences
$4.71 /

-0.02 (-0.42%)

ISRG Intuitive Surgical
$809.85 /

-0.91 (-0.11%)

IBKR Interactive Brokers
$74.23 /

-3.1 (-4.01%)

HWC Hancock Whitney
$40.83 /

-2.41 (-5.57%)

EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

CSX CSX
$98.51 /

-0.18 (-0.18%)

  • 21
    Apr
TRVG Trivago
$3.32 /

-0.255 (-7.13%)

THC Tenet
$51.92 /

-0.62 (-1.18%)

NFLX Netflix
$549.33 /

-5.17 (-0.93%)

LRN Stride
$30.75 /

+0.135 (+0.44%)

IBKR Interactive Brokers
$74.23 /

-3.1 (-4.01%)

TRVG Trivago
$3.32 /

-0.255 (-7.13%)

THC Tenet
$51.92 /

-0.62 (-1.18%)

NFLX Netflix
$549.33 /

-5.17 (-0.93%)

LRN Stride
$30.75 /

+0.135 (+0.44%)

ISRG Intuitive Surgical
$809.85 /

-0.91 (-0.11%)

IBKR Interactive Brokers
$74.23 /

-3.1 (-4.01%)

HWC Hancock Whitney
$40.83 /

-2.41 (-5.57%)

EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

NFLX Netflix
$549.33 /

-5.17 (-0.93%)

LRN Stride
$30.75 /

+0.135 (+0.44%)

ISRG Intuitive Surgical
$809.85 /

-0.91 (-0.11%)

IBKR Interactive Brokers
$74.23 /

-3.1 (-4.01%)

EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

CSX CSX
$98.51 /

-0.18 (-0.18%)

CPSH CPS Technologies
$7.59 /

-0.45 (-5.60%)

Hot Stocks
Edwards Lifesciences CEO says 'continued confidence' in 2021 outlook » 16:19
04/20/21
04/20
16:19
04/20/21
16:19
EW

Edwards Lifesciences

$89.62 /

+1.16 (+1.31%)

"We recognize that…

"We recognize that there are many people still struggling with the pandemic around the world, yet as we anniversary the start of the pandemic, I'm encouraged by the signs of recovery," said Michael Mussallem, chairman and CEO. "Structural heart procedures increased as we progressed through the winter months, and our sales growth this quarter was better-than-expected. Although we anticipate the effects of the pandemic will impact structural heart patients in the near term, we have continued confidence in our positive 2021 outlook."

ShowHide Related Items >><<
EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

04/15/21 Atlantic Equities
Atlantic Equities starts Edwards Lifesciences at Neutral
04/05/21 Evercore ISI
Evercore upgrades Edwards to Outperform ahead of its 'best pipeline cycle'
04/05/21 Evercore ISI
Edwards Lifesciences upgraded to Outperform from In Line at Evercore ISI
01/13/21 Piper Sandler
MCIT finalized rule 'important win' for medical technology, says Piper Sandler
EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

Earnings
Edwards Lifesciences sees Q2 adjusted EPS 54c-60c, consensus 52c » 16:18
04/20/21
04/20
16:18
04/20/21
16:18
EW

Edwards Lifesciences

$89.62 /

+1.16 (+1.31%)

Sees Q2 revenue…

Sees Q2 revenue $1.25B-$1.33B, consensus $1.25B.

ShowHide Related Items >><<
EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

04/15/21 Atlantic Equities
Atlantic Equities starts Edwards Lifesciences at Neutral
04/05/21 Evercore ISI
Evercore upgrades Edwards to Outperform ahead of its 'best pipeline cycle'
04/05/21 Evercore ISI
Edwards Lifesciences upgraded to Outperform from In Line at Evercore ISI
01/13/21 Piper Sandler
MCIT finalized rule 'important win' for medical technology, says Piper Sandler
EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

Earnings
Edwards Lifesciences raises FY21 adjusted EPS to $2.07-$2.27 from $2.00-$2.20 » 16:17
04/20/21
04/20
16:17
04/20/21
16:17
EW

Edwards Lifesciences

$89.62 /

+1.16 (+1.31%)

FY21 consensus $2.13.…

FY21 consensus $2.13. Back FY21 revenue view $4.9B-$5.3B, consensus $5.08B.

ShowHide Related Items >><<
EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

04/15/21 Atlantic Equities
Atlantic Equities starts Edwards Lifesciences at Neutral
04/05/21 Evercore ISI
Evercore upgrades Edwards to Outperform ahead of its 'best pipeline cycle'
04/05/21 Evercore ISI
Edwards Lifesciences upgraded to Outperform from In Line at Evercore ISI
01/13/21 Piper Sandler
MCIT finalized rule 'important win' for medical technology, says Piper Sandler
EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

Earnings
Edwards Lifesciences reports Q1 EPS 54c, consensus 47c » 16:15
04/20/21
04/20
16:15
04/20/21
16:15
EW

Edwards Lifesciences

$89.62 /

+1.16 (+1.31%)

Reports Q1 revenue $1.2B,…

Reports Q1 revenue $1.2B, consensus $1.16B.

ShowHide Related Items >><<
EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

04/15/21 Atlantic Equities
Atlantic Equities starts Edwards Lifesciences at Neutral
04/05/21 Evercore ISI
Evercore upgrades Edwards to Outperform ahead of its 'best pipeline cycle'
04/05/21 Evercore ISI
Edwards Lifesciences upgraded to Outperform from In Line at Evercore ISI
01/13/21 Piper Sandler
MCIT finalized rule 'important win' for medical technology, says Piper Sandler
EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.